Antibody arrays--an emerging tool in cancer proteomics

Int J Biochem Cell Biol. 2007;39(7-8):1305-17. doi: 10.1016/j.biocel.2007.04.029. Epub 2007 May 13.

Abstract

Cancer is a result of complex changes that occur in normal cells as they transform to become malignant and further when they become metastatic. These changes are not a consequence of a single protein but rather involve multiple proteins that function in pathways and networks. Thus, profiling cancer-associated changes requires simultaneous measurement of many proteins in a single sample. Identifying these changes may lead to the discovery of cancer-associated biomarkers that may assist in diagnosis, prognosis, patient monitoring and possibly for therapeutic purposes. Antibody arrays are a relatively new technology that enables one to perform multiplex high-throughput protein expression profiling. This review describes current technologies in antibody array and assay design, and presents a survey of the current literature on the use of these arrays in cancer research.

Publication types

  • Review

MeSH terms

  • Antibodies / immunology*
  • Humans
  • Neoplasms / diagnosis
  • Neoplasms / immunology*
  • Protein Array Analysis / methods
  • Proteomics / methods*

Substances

  • Antibodies